# FDA Inspection 965123 - AstraZeneca Pharmaceuticals LP - January 28, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/591ca477-34f4-4276-ac90-cbdfea8fdf2d
Source feed: FDA_Inspections

> FDA Inspection 965123 for AstraZeneca Pharmaceuticals LP on January 28, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 965123
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2016-01-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1218331 - 2023-09-19](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f66f66c2-0f6a-4aa1-972a-c17574142886)
- [FDA Inspection 853863 - 2013-10-25](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/abe000c7-f8bd-45af-b0af-2bb08474e3ed)
- [FDA Inspection 798609 - 2012-09-13](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/92cc88df-ce4e-4f65-a593-a36f9339c932)
- [FDA Inspection 751470 - 2011-10-28](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/5d401b01-20f7-49dd-b629-fc4aeae2f2cf)
- [FDA Inspection 741276 - 2011-08-12](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/49b21f43-de91-4fdb-b14b-59e59ab1d9c8)

Company: https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c